To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Update on Savannah Guthrie's Plans, Investigation into Nancy's Disappearance: She 'May Already Be Gone'

Austin's Liberal DA Makes Major Call About Officers Who Shot Suspected Terrorist that Killed 3, Injured Over a Dozen

Media Ignore Arrest of 14-Year Illegal Alien with 30 Arrests in Case of Virginia Bus Stop Stabbing Murder

Poll: 57 Percent of Americans Want All Illegal Migrants Sent Home

US Supreme Court Hands Unanimous Victory to Trump Administration on Asylum Cases

Pentagon Releases Identities of 6 US Soldiers Killed in Kuwait: 'They Laid Down Their Lives'

Hegseth: Iran Regime Is 'Toast' as Israel, US Broaden Strikes

Senator Fetterman Joins GOP to Block Iran War Powers Effort

President Trump Replaces Kristi Noem at DHS with Senator Markwayne Mullin

[Watch] After Fleeing the Regime Decades Ago, She Fights for a Free Iran and Exposes 'Islamic Radicalism'

'Madam President' Melania Trump Becomes First World Leader's Spouse to Chair UN Security Council

Former Indiana Music Teacher Wins Settlement after Being Forced to Resign for Not Using Trans Pronouns

3 Hero Austin Cops Who Stopped Deadly Bar Shooting Expected to Be Dragged before Grand Jury Thanks to George Floyd-Era Policy

Fetterman Chooses Country Over Party after Iran Operation

[Watch] If This Is True, the DNC Has a Moral Earthquake Coming

North Carolina, Texas Kick Off Contentious Midterm Primaries

'Failed to Act': Walz, Ellison Knew About Minnesota Fraud 'for Years,' House Report Claims

Third Blood Moon Landed Directly on Purim; So Many Signs in the Heavens

Esther, Purim, and The War in Iran

Tennessee Bill Seeking to Punish Women Who Have Abortions Divides Pro-Life Movement

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor